Best Practices for Hit-to-Lead - Case Study: HSD17B13

The Hit-to-Lead Process is a crucial part of an early drug discovery project.
This webinar highlights the strategy and key decision criteria for prioritization and subsequent optimization of chemical matter using the discovery of HSD17B13 inhibitor BI-3231 as an example.